Concepedia

M. Thill

MT

Statistics

Publications

4

Citations

62

H-Index

4

Active since

2019

Affiliations

Ludwig-Maximilians-Universität München(Current)

Agaplesion Markus Hospital

Praxis für Hämatologie und Onkologie

Evangelisches Krankenhaus Bethesda Mönchengladbach

Krankenhaus Köln-Holweide

M. Thill is an author at Ludwig-Maximilians-Universität München specializing in oncology, medicine, and treatment decision-making support.

Publications per year

2019–2025

4

Publications

4

Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study

Rachel Wuerstlein, Ronald Kates, Oleg Gluz et al. · Breast Cancer Research and Treatment · 2019 · 28 citations · Full text

Medicine, Molecular Medicine, Oncology +14

LBA14 Impact of age, recurrence score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials

Oleg Gluz, Ulrike Nitz, Matthias Christgen et al. · Annals of Oncology · 2022 · 13 citations

Medicine, Endocrinology, Gynecology +15

Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL

M. Thill, Mark‐Oliver Zahn, Anja Welt et al. · Breast Cancer Research and Treatment · 2023 · 11 citations · Full text

Medicine, Oncology, Surgery +17

189O Ribociclib + endocrine treatment vs SoC chemotherapy in intermediate risk HR+/HER2- early breast cancer: Results from the neoadjuvant cohort of the phase-III WSG ADAPTcycle – trial

N. Harbeck, Oleg Gluz, M Christgen et al. · ESMO Open · 2025 · 10 citations · Full text

Medicine, Endocrinology, Oncology +17

1–4 of 4